1. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor
   Song Liu et al, 2021, Journal of Medicinal Chemistry CrossRef
2. Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport
   Friederike Kosyna et al, 2018, Cells CrossRef
3. Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
   Antonella Lucia Marretta et al, 2021, Pharmaceutics CrossRef
4. Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
   Marije F. W. Semmelink et al, 2021, International Journal of Molecular Sciences CrossRef
5. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
   Qianqian Shan et al, 2020, The Korean Journal of Physiology & Pharmacology CrossRef
6. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data
   Hai-Yong Ren et al, 2015, BioMed Research International CrossRef
7. Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers
   Pauline J. van der Watt et al, 2022, International Journal of Cancer CrossRef
8. Small Molecule Inhibitors of CRM1
   Bibiana I. Ferreira et al, 2020, Frontiers in Pharmacology CrossRef
9. Therapeutic Targets for Bone and Soft-Tissue Sarcomas
   Shinji Miwa et al, 2019, International Journal of Molecular Sciences CrossRef
10. Targeting XPO1-Dependent Nuclear Export in Cancer
    Ekaterina Kim et al, 2022, Biochemistry (Moscow) CrossRef
11. Therapeutic Targeting of Exportin-1 in Childhood Cancer
    Basia Galinski et al, 2021, Cancers CrossRef
12. Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway
    Wen Yu Shao et al, 2017, Cancer Biology & Therapy CrossRef
13. Structural Basis of Targeting the Exportin CRM1 in Cancer
    Achim Dickmanns et al, 2015, Cells CrossRef
14. XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
    null Birnbaum et al, 2019, Journal of Clinical Medicine CrossRef